Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Investing Activities: 2015-2024

Historic Cash from Investing Activities for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $95.4 million.

  • Anaptysbio's Cash from Investing Activities rose 76.19% to $103.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.1 million, marking a year-over-year decrease of 28.07%. This contributed to the annual value of $95.4 million for FY2024, which is 34.10% down from last year.
  • Per Anaptysbio's latest filing, its Cash from Investing Activities stood at $95.4 million for FY2024, which was down 34.10% from $144.8 million recorded in FY2023.
  • Anaptysbio's 5-year Cash from Investing Activities high stood at $144.8 million for FY2023, and its period low was -$394.8 million during FY2022.
  • Its 3-year average for Cash from Investing Activities is -$51.6 million, with a median of $95.4 million in 2024.
  • Per our database at Business Quant, Anaptysbio's Cash from Investing Activities plummeted by 1,116.72% in 2022 and then surged by 136.66% in 2023.
  • Anaptysbio's Cash from Investing Activities (Yearly) stood at $94.5 million in 2020, then tumbled by 58.89% to $38.8 million in 2021, then tumbled by 1,116.72% to -$394.8 million in 2022, then spiked by 136.66% to $144.8 million in 2023, then tumbled by 34.10% to $95.4 million in 2024.